These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

856 related articles for article (PubMed ID: 23546565)

  • 1. Medical management to prevent recurrent nephrolithiasis in adults: a systematic review for an American College of Physicians Clinical Guideline.
    Fink HA; Wilt TJ; Eidman KE; Garimella PS; MacDonald R; Rutks IR; Brasure M; Kane RL; Ouellette J; Monga M
    Ann Intern Med; 2013 Apr; 158(7):535-43. PubMed ID: 23546565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dietary and pharmacologic management to prevent recurrent nephrolithiasis in adults: a clinical practice guideline from the American College of Physicians.
    Qaseem A; Dallas P; Forciea MA; Starkey M; Denberg TD;
    Ann Intern Med; 2014 Nov; 161(9):659-67. PubMed ID: 25364887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diet, fluid, or supplements for secondary prevention of nephrolithiasis: a systematic review and meta-analysis of randomized trials.
    Fink HA; Akornor JW; Garimella PS; MacDonald R; Cutting A; Rutks IR; Monga M; Wilt TJ
    Eur Urol; 2009 Jul; 56(1):72-80. PubMed ID: 19321253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of standard and low dose hydrochlorothiazide in the recurrence prevention of calcium nephrolithiasis (NOSTONE trial): protocol for a randomized double-blind placebo-controlled trial.
    Dhayat NA; Faller N; Bonny O; Mohebbi N; Ritter A; Pellegrini L; Bedino G; Schönholzer C; Venzin RM; Hüsler C; Koneth I; Del Giorno R; Gabutti L; Amico P; Mayr M; Odermatt U; Buchkremer F; Ernandez T; Stoermann-Chopard C; Teta D; Rintelen F; Roumet M; Irincheeva I; Trelle S; Tamò L; Roth B; Vogt B; Fuster DG
    BMC Nephrol; 2018 Dec; 19(1):349. PubMed ID: 30526528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Citrate salts for preventing and treating calcium containing kidney stones in adults.
    Phillips R; Hanchanale VS; Myatt A; Somani B; Nabi G; Biyani CS
    Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD010057. PubMed ID: 26439475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of dietary treatment and fluid intake on the prevention of recurrent calcium stones and changes in urine composition: A meta-analysis and systematic review.
    Wang Z; Zhang Y; Wei W
    PLoS One; 2021; 16(4):e0250257. PubMed ID: 33872340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of renal stone disease recurrence. A systematic review of contemporary pharmaceutical options.
    Sfoungaristos S; Gofrit ON; Yutkin V; Pode D; Duvdevani M
    Expert Opin Pharmacother; 2015 Jun; 16(8):1209-18. PubMed ID: 25881654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uricosuric medications for chronic gout.
    Kydd AS; Seth R; Buchbinder R; Edwards CJ; Bombardier C
    Cochrane Database Syst Rev; 2014 Nov; (11):CD010457. PubMed ID: 25392987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Empiric Preventative Pharmacologic Therapies on Stone Recurrence Among Patients with Kidney Stone Disease.
    Hsi RS; Yan PL; Crivelli JJ; Goldfarb DS; Shahinian V; Hollingsworth JM
    Urology; 2022 Aug; 166():111-117. PubMed ID: 35545149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological interventions for preventing complications in idiopathic hypercalciuria.
    Escribano J; Balaguer A; Pagone F; Feliu A; Roqué I Figuls M
    Cochrane Database Syst Rev; 2009 Jan; 2009(1):CD004754. PubMed ID: 19160242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treated and untreated recurrent calcium nephrolithiasis in patients with idiopathic hypercalciuria, hyperuricosuria, or no metabolic disorder.
    Coe FL
    Ann Intern Med; 1977 Oct; 87(4):404-10. PubMed ID: 907239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis of randomized trials for medical prevention of calcium oxalate nephrolithiasis.
    Pearle MS; Roehrborn CG; Pak CY
    J Endourol; 1999 Nov; 13(9):679-85. PubMed ID: 10608521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary prevention of nephrolithiasis is cost-effective for a national healthcare system.
    Lotan Y; Buendia Jiménez I; Lenoir-Wijnkoop I; Daudon M; Molinier L; Tack I; Nuijten MJ
    BJU Int; 2012 Dec; 110(11 Pt C):E1060-7. PubMed ID: 22686216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospects for dietary therapy of recurrent nephrolithiasis.
    Goldfarb DS
    Adv Chronic Kidney Dis; 2009 Jan; 16(1):21-9. PubMed ID: 19095202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation and medical management of kidney stones in children.
    Tasian GE; Copelovitch L
    J Urol; 2014 Nov; 192(5):1329-36. PubMed ID: 24960469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physiological and physiochemical correction and prevention of calcium stone formation by potassium citrate therapy.
    Pak CY; Sakhaee K; Fuller CJ
    Trans Assoc Am Physicians; 1983; 96():294-305. PubMed ID: 6679957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prevention of nephrolithiasis: a review].
    Ferraro PM; Lombardi G; Gambaro G
    Urologia; 2014; 81(2):88-92. PubMed ID: 24915149
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 43.